thiopental inresa süstelahuse pulber
inresa arzneimittel gmbh - tiopentaal - süstelahuse pulber - 1000mg 25tk; 1000mg 10tk
ketamin inresa süstelahus
inresa arzneimittel gmbh - ketamiin - süstelahus - 50mg 1ml 10ml 5tk
naloxon inresa süstelahus
inresa - naloksoon - süstelahus - 0,4mg 1ml 1ml 10tk
erythromycin inresa infusioonilahuse pulber
inresa arzneimittel gmbh - erütromütsiin - infusioonilahuse pulber - 1g 10tk
vecuronium inresa 10mg süstelahuse pulber
inresa arzneimittel gmbh - vekurooniumbromiid - süstelahuse pulber - 10mg 10tk
esketamin inresa süste-/infusioonilahus
g.l. pharma gmbh - esketamiin - süste-/infusioonilahus - 25mg 1ml 2ml 10tk
xtandi
astellas pharma europe b.v. - ensalutamiid - eesnäärmevähk - endokriinset ravi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
enzalutamide sandoz õhukese polümeerikattega tablett
sandoz pharmaceuticals d.d. - ensalutamiid - õhukese polümeerikattega tablett - 80mg 14tk
enzalutamide sandoz õhukese polümeerikattega tablett
sandoz pharmaceuticals d.d. - ensalutamiid - õhukese polümeerikattega tablett - 40mg 112tk